Health & bio

FDA Approves Lilly's Oral GLP-1 'Foundayo' April 1 Via Fast-Track

The FDA cleared Lilly's orforglipron (brand name Foundayo) through a newly established CNP voucher fast-track pathway on April 1.

Primary sources · 1
← View the full 2026-04-08 (Wednesday) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →